These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6754748)

  • 1. In vitro complement binding on cytoplasmic structures in normal human skin: immunoelectronmicroscopic studies.
    Schuler G; Hintner H; Wolff K; Fritsch P; Stingl G
    J Cell Biol; 1982 Nov; 95(2 Pt 1):543-51. PubMed ID: 6754748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro complement binding in human skin cells with altered differentiation.
    Hintner H; Stanzl U; Schuler G; Klein G; Fritsch P; Stingl G
    J Invest Dermatol; 1983 Jun; 80(6):490-3. PubMed ID: 6343513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-independent binding of Clq and activation of serum complement by human skin in vitro.
    Linder E
    J Invest Dermatol; 1982 Feb; 78(2):116-20. PubMed ID: 7035571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by C-reactive protein on the HEp-2 cell substrate.
    Vaith P; Prasauskas V; Potempa LA; Peter HH
    Int Arch Allergy Immunol; 1996 Oct; 111(2):107-17. PubMed ID: 8859218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of complement by intermediate filaments of glomerular epithelial cells.
    Linder E; Helin H; Rantala I
    Clin Immunol Immunopathol; 1986 Aug; 40(2):265-75. PubMed ID: 3521974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the receptors for activated complement on the visceral epithelial cells by the human renal glomerulus by immunoenzymatic microscopy.
    Carlo JR; Ruddy S; Conway AF
    Am J Clin Pathol; 1981 Jan; 75(1):23-7. PubMed ID: 7006378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy.
    Wozencraft AO; Sayers G; Blackwell JM
    J Exp Med; 1986 Oct; 164(4):1332-7. PubMed ID: 3531384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructure of human skin by a rapid freezing technique: structural preservation and antigenicity.
    Aoki N; Ito M; Ejiri S; Ozawa H
    J Invest Dermatol; 1994 Mar; 102(3):354-61. PubMed ID: 8120419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to complement factors and activation of the alternative pathway by Acanthamoeba.
    Pumidonming W; Walochnik J; Dauber E; Petry F
    Immunobiology; 2011; 216(1-2):225-33. PubMed ID: 20627448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of complement on the surface of cells infected by human immunodeficiency virus.
    Spear GT; Landay AL; Sullivan BL; Dittel B; Lint TF
    J Immunol; 1990 Feb; 144(4):1490-6. PubMed ID: 1968081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.
    Theofilopoulos AN; Perrin LH
    J Exp Med; 1976 Feb; 143(2):271-89. PubMed ID: 1082488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
    Bartolotti SR; Peters DK
    Clin Exp Immunol; 1979 Sep; 37(3):391-8. PubMed ID: 389495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoelectronmicroscopic examination of early lesions in histamine induced immune complex vasculitis in man.
    Wolff HH; Maciejewski W; Scherer R; Braun-Falco O
    Br J Dermatol; 1978 Jul; 99(1):13-24. PubMed ID: 150283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells.
    Hindmarsh EJ; Marks RM
    J Immunol; 1998 Jun; 160(12):6128-36. PubMed ID: 9637530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.